News Archive

Petro C et al., HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates, JCI Insight. 2016;1(12).

ncbi.nlm.nih.gov/pmc/articles/PMC4985247/

Petro C et al., HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates, JCI Insight. 2016;1(12).Arne2019-06-28T05:51:40+00:00

Bolland S, Pierce SK, Ups and downs in the search for a herpes simplex virus vaccine, eLife. 2015;4.

ncbi.nlm.nih.gov/pmc/articles/PMC4354104/

Bolland S, Pierce SK, Ups and downs in the search for a herpes simplex virus vaccine, eLife. 2015;4.Arne2019-06-28T05:54:09+00:00

Petro C et al., Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease, eLife. 2015;4.

ncbi.nlm.nih.gov/pmc/articles/PMC4352706/

Petro C et al., Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease, eLife. 2015;4.Arne2019-05-20T13:08:11+00:00

HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985247/

HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolatesArne2018-12-20T12:24:31+00:00

Ups and downs in the search for a Herpes simplex virus vaccine.

https://www.ncbi.nlm.nih.gov/pubmed/25756748

Ups and downs in the search for a Herpes simplex virus vaccine.Arne2018-11-07T09:36:12+00:00

Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352706/

Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural diseaseArne2018-11-07T09:35:01+00:00